Toronto Innovation Acceleration Partners – TIAP – specializes in venture building of
early-stage health science technologies emerging from our members.
TIAP was formerly MaRS Innovation
TIAP’s President & CEO, Parimal Nathwani, is appointed to the Government of Canada’s COVID-19 Core Task Force to advise on funding of new and potential therapies for COVID-19:
Toronto, Ontario, June 04, 2020 (GLOBE NEWSWIRE) — Toronto Innovation Acceleration Partners (TIAP) announced today the launch of a new LAB150 project aimed at developing a novel therapeutic agent for immuno-oncology. The research for …
TORONTO, May 12, 2020 (GLOBE NEWSWIRE) — Toronto Innovation Acceleration Partners (TIAP), Evotec SE and AmorChem II Fund L.P. (AmorChem) are pleased to announce a $1.75M investment into a drug development project focused on …